Onconova Therapeutics Price on July 19, 2023

ONTXDelisted Stock  USD 1.02  0.04  3.77%   
If you're considering investing in Onconova Stock, it is important to understand the factors that can impact its price. As of today, the current price of Onconova Therapeutics stands at 1.02, as last reported on the 13th of December 2024, with the highest price reaching 1.07 and the lowest price hitting 1.01 during the day. We have found twenty-nine technical indicators for Onconova Therapeutics, which you can use to evaluate the volatility of the company. Please check Onconova Therapeutics' Coefficient Of Variation of 1047.88, risk adjusted performance of 0.0785, and Semi Deviation of 4.35 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Onconova Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ONTX
Based on monthly moving average Onconova Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Onconova Therapeutics by adding Onconova Therapeutics to a well-diversified portfolio.

Onconova Therapeutics Valuation on July 19, 2023

It is possible to determine the worth of Onconova Therapeutics on a given historical date. On July 19, 2023 Onconova was worth 1.15 at the beginning of the trading date compared to the closed value of 1.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Onconova Therapeutics stock. Still, in general, we apply an absolute valuation method to find Onconova Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Onconova Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Onconova Therapeutics' related companies.
 Open High Low Close Volume
  1.09    1.14    1.09    1.12    55,832  
07/19/2023
  1.15    1.15    1.10    1.11    51,117  
  1.10    1.12    1.09    1.10    28,306  
Backtest Onconova Therapeutics  |  Onconova Therapeutics History  |  Onconova Therapeutics Valuation   PreviousNext  
Open Value
1.15
1.11
Closing Value
1.15
Upside

Onconova Therapeutics Trading Date Momentum on July 19, 2023

On July 20 2023 Onconova Therapeutics was traded for  1.10  at the closing time. The top price for the day was 1.12  and the lowest listed price was  1.09 . The trading volume for the day was 28.3 K. The trading history from July 20, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.90% . The trading delta at closing time against the current closing price is 4.50% .

Onconova Therapeutics Fundamentals Correlations and Trends

By evaluating Onconova Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Onconova Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Onconova financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Onconova Therapeutics Stock history

Onconova Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Onconova is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Onconova Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Onconova Therapeutics stock prices may prove useful in developing a viable investing in Onconova Therapeutics
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania. Onconova Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.

Onconova Therapeutics Stock Technical Analysis

Onconova Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Onconova Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Onconova Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Onconova Therapeutics Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Onconova Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Onconova Therapeutics December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how Onconova Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Onconova Therapeutics shares will generate the highest return on investment. By undertsting and applying Onconova Therapeutics stock market strength indicators, traders can identify Onconova Therapeutics entry and exit signals to maximize returns

Onconova Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Onconova Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Onconova Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Onconova to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Onconova Stock

If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets